Unlock instant, AI-driven research and patent intelligence for your innovation.

Target spot for diagnosing and treating intracranial aneurysm and application of target spot

An intracranial aneurysm and preparation technology, which is applied in the field of tumor markers, can solve the problem of no research revealing the relationship between intracranial aneurysms, etc., and achieve the effects of good application prospects, strong selectivity, and rapid and accurate quantification.

Inactive Publication Date: 2016-03-23
SICHUAN PROVINCIAL PEOPLES HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The inventors performed high-throughput sequencing on the tissue samples of 5 cases of intracranial aneurysm and 3 cases of the control group, combined with bioinformatics methods for gene screening, and selected the highly expressed candidate gene HAPLN1 from the genes with obvious differential expression. Studies have shown that HAPLN1 is related to pseudochondroplasia, but no research has revealed its relationship with intracranial aneurysms. The inventors conducted molecular verification and confirmed that HAPLN1 is highly expressed in the intracranial aneurysm group

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Target spot for diagnosing and treating intracranial aneurysm and application of target spot
  • Target spot for diagnosing and treating intracranial aneurysm and application of target spot
  • Target spot for diagnosing and treating intracranial aneurysm and application of target spot

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The collection of embodiment 1 case

[0035] All tissue samples came to the neurosurgery department of the hospital from October 2012 to May 2014 in patients with intracranial aneurysms diagnosed by DSA, and underwent microsurgical craniotomy. The aneurysm tissue samples were the aneurysm wall tissue removed during microsurgery, and the control normal cerebrovascular tissue samples were the superficial temporal artery (STA) and / or middle meningeal artery (MMA) of brain tumor craniotomy patients at the same period. In order to minimize the differences between samples, all aneurysm tissue samples were selected from saccular aneurysms. The obtained tissue samples were immediately placed in a liquid nitrogen tank.

Embodiment 2

[0036] Example 2 extracts the total RNA in the sample

[0037] 1) Put small pieces of aneurysm (normal control blood vessel) tissue in a petri dish, add 1ml Trizol, cut it into pieces with ophthalmic scissors, and transfer to a homogenizer for homogenization;

[0038] 2) After the homogenization is completed, take out the homogenate and place it in an EP tube, set the volume to 1ml, and store it at -70°C;

[0039] 3) Place at 15-30°C for 5 minutes, add 200 μl chloroform, shake vigorously for 15 sec, and place at 15-30°C for 10 minutes;

[0040] 4) 2-8°C, centrifuge at lower than 12000g / min for 10min, discard the supernatant, add 1ml of 75% ethanol, centrifuge at lower than 7500g / min for 5min, discard the supernatant, and spot off;

[0041] 5) After the precipitate is dried (it is translucent, do not completely dry, otherwise the stability will be reduced), dissolve it with RNase-freewater at 55-60°C, and freeze it at -70°C.

Embodiment 3

[0042] Example 3 High-throughput sequencing and analysis

[0043] After RNA extraction, agarose gel electrophoresis is performed. From the results of electrophoresis, it can be preliminarily judged whether the quality of the extracted RNA sample is qualified or not, and whether it can be used for further transcriptome sequencing. Then, the extraction of RNA samples was detected by NanoDrop1000 spectrophotometer, and the sample requirements for RNA-seq sequencing: OD260 / OD280 was 1.8-2.2. The qualified samples were sent to the sequencing company for sequencing. The sequencing platform was the HiSeq2500 high-throughput sequencing platform of Illumina Company for high-throughput transcriptome deep sequencing. The results of data analysis provided by the sequencing company were combined with the literature to screen the differentially expressed gene HAPLN1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
pore sizeaaaaaaaaaa
control rateaaaaaaaaaa
Login to View More

Abstract

The invention relates to a target spot for diagnosing and treating intracranial aneurysm and application of the target spot. The target spot and the application thereof are characterized in that an inventor selects a candidate gene HAPLN1 on the basis of high-throughput sequencing result; the RT-PCR (Reverse Transcription-Polymerase Chain Reaction) verification result proves that HAPLN1 mRNA (messenger Ribonucleic Acid) is highly expressed in an intracranial aneurysm group, and an interference experiment displays the transfer ability of EPCs(Endothelial Progenitor Cell) can be greatly improved by inhibiting the expression of the HAPLN1. The invention provides a new potential treatment target spot for the intracranial aneurysm; the new potential treatment target spot has important clinical application value.

Description

technical field [0001] The present invention relates to tumor markers, in particular to a target for diagnosis and treatment of intracranial aneurysms and its application, more specifically to the application of HAPLN1 gene and its expression products in the diagnosis and treatment of intracranial aneurysms. Background technique [0002] The etiology and pathogenesis of intracranial aneurysm (IA) are complex. The research on the etiology and mechanism of IA has always been the focus and hot spot of cerebrovascular disease research at home and abroad. It is generally believed that the formation, development and rupture of IA are caused by multiple factors such as genetics, smoking, age, environment, atherosclerosis, hypertension and hyperlipidemia, and hemodynamic changes. With the deepening of its research, people have gradually realized that hemodynamic factors play a very important role in the occurrence, development and rupture of IA. IA usually occurs in Willis arterial...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68G01N33/68A61K45/00A61K48/00A61P9/00
CPCA61K45/00A61K48/00C12Q1/6883C12Q2600/158G01N33/68G01N2800/329
Inventor 李志立黄光富陈隆益谭海斌王振宇石毅刘泠殷成王奇
Owner SICHUAN PROVINCIAL PEOPLES HOSPITAL